References
- Lichtman MA, Rowe JM. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations. Blood 1982: 60(2): 279–83
- Williams EC, Mosher DE. Disseminated intravascular coagulation. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al, eds. Hematology: basic principles and practice. New York: Churchill Livingstone, 1991: 1394–6
- Hardaway RM 3d. Disseminated intravascular coagulation as a possible cause of acute respiratory failure. Surg Gynecol Obstet 1973: 137(3): 419–23
- Umeki S, Adachi M, Watanabe M, et al. Gabexate as a therapy for disseminated intravascular coagulation. Arch Intern Med 1988: 148(6): 1409–12
- Rodeghiero F, Awisati G, Castaman G, et al. Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia: a GIMEMA retrospective study in 268 consecutive patients. Blood 1990: 75(11): 2112–7
- Goldberg MA, Ginsburg D, Mayer RJ, et al. Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 1987: 69(1): 187–91
- Kuter DJ, Ellman L, McCluskey RT. An 85-year-old woman with renal failure, neurologic deterioration, and seizures. N Engl J Med 1991: 325(4): 265–73
- Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura: Canadian Apheresis Study Group. N Engl J Med 1991: 325(6): 393–7
- Bell WR, Braine HG, Ness PM, et al. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: clinical experience in 108 patients. N Engl J Med 1991: 325(6): 398–403